These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. Girard PM; Bouchaud O; Goetschel A; Mukwaya G; Eestermans G; Ross M; Rozenbaum W; Saimot AG AIDS; 1996 Jun; 10(7):753-7. PubMed ID: 8805866 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228 [TBL] [Abstract][Full Text] [Related]
6. Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma. Uthayakumar S; Bower M; Money-Kyrle J; Muyshondt C; Youle M; Hannon F; Phillips R; Gazzard BG; Boag F AIDS; 1996 May; 10(5):515-9. PubMed ID: 8724043 [TBL] [Abstract][Full Text] [Related]
11. Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. Rosenthal E; Poizot-Martin I; Saint-Marc T; Spano JP; Cacoub P; Am J Clin Oncol; 2002 Feb; 25(1):57-9. PubMed ID: 11823698 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906 [TBL] [Abstract][Full Text] [Related]
13. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. Harrison M; Tomlinson D; Stewart S J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of liposomal daunorubicin and its use in Kaposi's sarcoma. Chew T; Jacobs M Oncology (Williston Park); 1996 Jun; 10(6 Suppl):28-33; discussion 37-8. PubMed ID: 16871707 [TBL] [Abstract][Full Text] [Related]
15. Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. Money-Kyrle JF; Bates F; Ready J; Gazzard BG; Phillips RH; Boag FC Clin Oncol (R Coll Radiol); 1993; 5(6):367-71. PubMed ID: 8305357 [TBL] [Abstract][Full Text] [Related]
17. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group. Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755 [TBL] [Abstract][Full Text] [Related]
18. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262 [TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma: DaunoXome approved. AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485 [TBL] [Abstract][Full Text] [Related]
20. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. Dezube BJ; Von Roenn JH; Holden-Wiltse J; Cheung TW; Remick SC; Cooley TP; Moore J; Sommadossi JP; Shriver SL; Suckow CW; Gill PS J Clin Oncol; 1998 Apr; 16(4):1444-9. PubMed ID: 9552050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]